Products in Development

The NanOlogy therapeutic platform is composed of patented large surface area microparticles (LSAMs) of pure drug designed for tumor-directed therapy via intratumoral, peritoneal, intravesicular, inhalation, and other routes of local administration.

NANO2019productsgroupingNuNebuwide
NanoPac®
(LSAM Paclitaxel) for Suspension

Ovarian Cancer (intraperitoneal)
Prostate Cancer (intratumoral)
Pancreatic Cancer (intratumoral)
Pancreatic Mucinous Cysts (intracystic)
Lung Cancer (intratumoral/nodal)

NanoDoce®
(LSAM Docetaxel) for Suspension

Bladder Cancer (resection bed injection)
Renal Cancer (intratumoral)

NanoPac®
(LSAM Paclitaxel) for Nebulized Inhalation

Lung Cancer (inhalation)

SOR007
 (Topical Submicron Particle Paclitaxel Suspended in Anhydrous Base)

Cutaneous Metastases
Actinic Keratosis